The vision of TREC is to diminish the suffering and burden of venous thrombosis by discovering novel risk factors and disease mechanisms to facilitate personalized prevention and treatment.
TREC is a translational research center which fosters the multidirectional integration of laboratory-, patient-oriented-, and population-based research.
TREC affiliated MD students have graduated from the Research program in medicine
02.12.2025
Is mannose binding lectin of the lectin complement pathway associated with risk of venous thromboembolism (VTE)?
01.12.2025
Prizes to TREC at ECTH2025
TREC affiliated MD students have graduated from the Research program in medicine
Feiring med kake etter forskerlinjeeksamen Foto: John-Bjarne Hansen
The Research Program in Medicine (Forskerlinjen) at UiT The Arctic University of Norway is a 120 ECTS credit program, of which 30 credits are for PhD courses and 90 credits are for a research project. The program is anually offered to 10 MD students who wish to pursue a research career. The program provides students with practical research experience, training in research methods and critical thinking, along with a solid foundation for further PhD studies. The Research Program in Medicine ends with oral examination consisting of 20 minutes presentation of the student’s research project by the students followed by 40 minutes defense with one external and one internal examinator during the sixth year at medical school.
During the last 15 years, the Thrombosis Research Group (TREC) has recruited 1-2 of the students elected for the research program annually for thrombosis-related projects. This year, however, we had for the first time 3 MD/PhD students (Camilla Langholm, Nikolai Hagensen Eide, and Asbjørn Lund Onsaker) that graduated from the program on Friday November 28. They all presented papers published in high-ranked medical journals and defended their projects exceptionally well during the scientific discussions. The external evaluator for all three graduations was professor Pål Andre Holme from the University of Oslo.
The achievements were traditionally celebrated with coffee and cake immediately after graduation with colleagues, family and friends in TREC premises at UiT.
The following papers were discussed during the exams:
Is mannose binding lectin of the lectin complement pathway associated with risk of venous thromboembolism (VTE)?
The complement system, a fundamental part of humoral and innate immunity, has gained considerable attention for its interplay with coagulation and potential role in the pathogenesis of VTE. Mannose-binding lectin (MBL), a pattern recognition molecule circulates in complexes with MBL-associated serine proteases (MASPs) in blood. The MASPs are activated when MBL bind to specific carbohydrate patterns on pathogens or altered host cells and lead to downstream complement activation. In the present population-based study, we found that individuals with high plasma MBL levels had 79% higher VTE risk than those with low MBL levels, and that activated MBL-MASP complexes facilitated thrombin generation independent of downstream complement activation. The results suggest that high MBL levels are a risk factor for VTE partly mediated by direct thrombin generation at the site of venous thrombosis formation. Our findings were recently published and highlighted as a featured paper in Arteriosclerosis Thrombosis and Vascular Biology.
The first author of this study, Christabel Esi Damoah, is a PhD-student at TREC and the study included collaborators from Norway, Denmark, Hungary and USA.
Graphical Abstract. Damoah et al. ATVB 2025 Published: 02.12.2025
Link to this page
Prizes to TREC at ECTH2025
The European Congress on Thrombosis and Haemostasis (ECTH), which is held every second year, was held in Prague on October 22-24. The conference had 500 participants and a group of 16 members from TREC attended. We presented the most recent results from our projects, and three of our MD/PhD-students (forskerlinjestudenter) and PhD-students received awards.Young investigator awards to Mathias and Solveig (left), Science Fast and Furious (middle), Prague Castle (right). Photos: Sigrid Brækkan
TREC submitted 15 abstracts to the conference (total number of abstracts were >300), and of these, 12 were elected for oral presentations, one for “Science fast and furious”, and the remaining two were presented as posters. The “Science fast and furious” is a scientific presentation in a TED-talk format, and the eight highest ranked abstracts are elected for this session. Mathias Haugmo Storvand did a great job on the fast and furious stage, presenting results on a newly discovered protein which is linked to obesity-related VTE. Together with Solveig Marie Valderhaug he received a young investigator award, while Maryam Hosseini won the prize for best poster presentation!
The TREC members held presentations within the sessions on venous thromboembolism (VTE), recurrent thrombosis, platelets, cancer-related VTE and obesity-related VTE. Anna Arntzen, Camilla Langholm, Celina Cathro, Christopher Antoun, Eduarda Guerreiro, John-Bjarne Hansen, Nikolai Eide, Magdalena Johansson, Maryam Hosseini, Melliane Olsen, Lukas Konecny and Solveig Valderhaug all did an excellent job presenting their work!
The scientific program of the conference was truly inspiring, and it was nice to meet colleagues and researchers in the field of thrombosis and hemostasis from all over Europe.
We had a great time in Prague!
Celina Cathro presenting (left), Networking event (middle), Best Poster prize to Maryam Hosseini (right). Photos: Sigrid Brækkan Published: 01.12.2025
Link to this page
Clinical epidemiology and risk factors of venous thromboembolism, Diagnostic and predictive biomarkers of venous thromboembolism, Pathophysiology of venous thromboembolism
Current positions:
Head of Thrombosis Research Group (TREC)
Head of Thrombosis Research Center (TREC), University Hospital of North Norway
Publications
>300 original full papers in peer-reviewed journals listed in PubMed and 22 review articles and 12 book chapters. Contributed to >370 abstracts presented at and published in conjunction with scientific international meetings/conferences. H-index: 51.
Supervision of PhD-students and postdoctors
Completed PhDs: Main supervisor: 35; Co-supervisor: 5
Ongoing PhDs: 7 as main supervisor and 6 as co-supervisor
Mentor for 13 previous and 3 present postdoctors
Other relevant professional experiences
2016-21 Chair of the Subcommittee Diagnostic and predictive variables, ISTH
2015-20 Member of the scientific program committee of the European Haematology Association (EHA)
2015- Member of the organization committee of the European Congress of Thrombosis and Haemostasis (ECTH)
2015 - Associate investigator Centre for Molecular Medicine Norway (NCMM)
2014 -20 Associate editor Journal of Thrombosis and Haemostasis
My main research interest is the epidemiology and pathogenesis of venous thromboembolism (VTE). In order to optimize prevention and treatment of the disease, it is crucial to better understand the mechanisms of venous thrombus formation and how risk factors contribute to or interplay in this process.
I have trained as an epidemiologist within the field of thrombosis and hemostasis, and worked with studies on the relationship between arterial and venous thrombosis, life-style factors and VTE, biomarkers for future VTE, cancer-related VTE, as well as complications after VTE.
Affiliated with TREC in 20% Professor II position, employed by UNN. Full-time Professor at Department of Clinical Medicine, UiO (Research Group: Inflammatory biomarkers in cardiovascular and metabolic disease)
I am a medical doctor and approved specialist in Internal Medicine and Hematology in Brazil. I obtained my first PhD (Hematology) in Brazil in 2000. Given my growing interest in research on the epidemiology of venous thromboembolism (VTE), I moved to the Netherlands in 2014 and started a second PhD at the Department of Clinical Epidemiology (Leiden University Medical Center - LUMC). After obtaining my PhD at LUMC in 2017, I joined the Thrombosis Research Group (TREC) at UiT – The Arctic University of Norway as a researcher.
My main research interest is the epidemiology and pathophysiology of VTE, with a special focus on the investigation of novel VTE biomarkers that could serve as potential targets for VTE prevention and treatment. I have contributed to >65 original full papers in peer-reviewed journals in PUBMED (about 60% of which published from 2019 onwards). I have supervised 3 PhD-students as main supervisor and 4 as co-supervisor to completion of PhD. I am currently main supervisor for 2 and co-supervisor for 4 PhD-students. Since 2022, I have served as Associate Editor in Research and Practice in Thrombosis and Haemostasis (RPTH), the Open Access journal of the International Society on Thrombosis and Haemostasis (ISTH). In 2021 and 2022, I received awards for Outstanding Editorial Board Performance in RPTH.
Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037 Norway
Pharmacy Building, 4th Floor (F4.210), Universitetsvegen 57, 9019 Tromsø john-bjarne.hansen@uit.no Show map